Sam Waksal

(redirected from Samuel D. Waksal)
Also found in: Financial, Wikipedia.
Founder of the biopharmaceutical company ImClone who was convicted of insider trading
References in periodicals archive ?
patents gives ImClone and Abbott, a strong proprietary position for RCR technology worldwide," stated Samuel D.
The claims against all defendants would be dismissed with prejudice but the Company would retain the right to continue to pursue certain claims against its former chief executive officer, Samuel D.
3 million, an amount representing the withholding tax liability attributable to Samuel D.
ImClone Systems Incorporated (NASDAQ:IMCL), today announced that Samuel D.
The action is pending in the United States District Court, Southern District of New York, located at 500 Pearl Street, New York, NY 10007, against defendants ImClone, Samuel D.
We will be working closely with the FDA toward the goal of an expeditious acceptance of our BLA," stated Samuel D.
We are very pleased to join the ranks of the world's most impressive entrepreneurial companies," commented Samuel D.